Answer
Breastfeeding should be discontinued during treatment with Venclyxto (venetoclax), because excretion of venetoclax or its metabolites into human milk is unknown and a risk to the breastfed child cannot be excluded.
Sources for this answer
- Venclyxto 10mg film-coated tabletsAbbVie Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 26Document updated
Sources checked